Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Peripheral nerve stimulation & intrathecal pumps · Alabama | Peripheral nerve stimulation & intrathecal pumps · Texas | |
|---|---|---|
| Surgeons, 2024 | 6 | 60 |
| Medicare fee-for-service cases | 319 | 4,698 |
| Growth since 2019 (Medicare FFS) | +4.8%/yr | +15%/yr |
| Forecast cases (Medicare FFS) | 670 in 2030 | 9,310 in 2030 |
| Forecast growth | +13%/yr to 2030 | +12%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.7 | 2.0 |
| Medicare Advantage share | 64% | 59% |
| Out of hospital | 49% (−5 pts since 2019) | 72% (+38 pts since 2019) |
| Cases per surgeon | 53 | 78 |
| Top 10 surgeons' share | 100% | 39% |
| Surgeons growing | 0 | 4 |
| New since the base year | 1 | 17 |
| Likely to stop billing it | 3 by 2026 | 9 by 2026 |
| Forecast miss, 1 year (procedure) | 11% | 11% |
| Company payments per surgeon | $9,803 | $8,870 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.